(Q30668998)

26 June 2017

title

Sphingolipid activator proteins are required for epidermal permeability barrier formation (English)

1 reference

26 June 2017

1 reference

Doering T

1 reference

26 June 2017

Holleran WM

1 reference

26 June 2017

Potratz A

1 reference

26 June 2017

Vielhaber G

1 reference

26 June 2017

Elias PM

1 reference

26 June 2017

Suzuki K

1 reference

26 June 2017

Sandhoff K

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Journal of Biological Chemistry

26 June 2017

1 reference

inferred from page(s)

published in

1 reference

26 June 2017

volume

274

1 reference

26 June 2017

1 reference

26 June 2017

page(s)

11038-11045

1 reference

The activator of cerebroside-sulphatase. A model of the activation

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Sphingolipid metabolism in organotypic mouse keratinocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

The composition of the ceramides from human stratum corneum and from comedones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Specificity of low molecular weight glycoprotein effector of lipid glycosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Effect of saposins on acid sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Occurrence of prosaposin as a neuronal surface membrane component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

Ceramide composition of the psoriatic scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.16.11038

21 January 2018

Identifiers

DOI

10.1074/JBC.274.16.11038

1 reference

26 June 2017

1 reference